<DOC>
	<DOCNO>NCT01111851</DOCNO>
	<brief_summary>This study evaluate mean value brain neurokinin 1 ( NK1 ) -receptor occupancy participant treat aprepitant similar participant treat fosaprepitant certain timepoints .</brief_summary>
	<brief_title>Aprepitant Fosaprepitant Time-on-Target PET ( Positron Emission Tomography ) Study ( 0869-183 )</brief_title>
	<detailed_description>The third arm study ( Aprepitant 250 mg ) conduct real-time assessment NK1-receptor occupancy data fosaprepitant 150 mg &amp; aprepitant 165 mg reveals primary hypothesis support .</detailed_description>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Aprepitant</mesh_term>
	<mesh_term>Fosaprepitant</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Generally healthy Female participant must nonchildbearing potential Nonsmoker use nicotine nicotinecontaining product least 6 month History clinically significant psychiatric disorder last 5 10 year History stroke , chronic seizure , major neurological disorder History clinically significant endocrine , gastrointestinal , cardiovascular , hematological , hepatic , immunological , renal , respiratory , genitourinary abnormality diseases History neoplastic disease Excessive consumption alcohol ( 3 drinks/day ) caffeinated beverage ( 6 servings/day ) Major surgery , donate lose 1 unit blood within 4 week Participated another investigational study within 4 week History significant drug allergy clinically significant adverse experience relate EMENDâ„¢ , dexamethasone , ondansetron History significant multiple and/or severe allergy History anaphylactic reaction significant intolerability prescription nonprescription drug food Current drug/alcohol abuse , history within 2 year Participation PET study study involve administration radioactive substance ionize radiation within prior 12 month Extensive radiological examination within prior 12 month Magnetizable metal prosthesis device ( Magnetic Resonance Imaging ( MRI ) hazard ) History claustrophobia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>NK1-receptor occupancy</keyword>
</DOC>